Role of hepatocyte growth factor on cardiomyocyte apoptosis and left ventricular remodeling after acute myocardial infarction

宋明宝,黄岚,李爱民,蒋世忠,张坡,于世勇,武晓静,赵刚,晋军,藤海军

DOI: https://doi.org/10.3321/j.issn:1673-8225.2004.21.033

2004-01-01

Abstract:Aim: To explore the effect of hepatocyte growth factor (HGF) on cardiomyocyte apoptosis and left ventricular remodeling after acute myocardial infarction (AMI). Methods: A total of 56 New Zealand rats were randomized into 4 groups: sham-operation group, sham-operation + HGF group, control group and intervention group. AMI model was established by ligating left coronary artery anterior descending branch. Animals in the intervention group were injected intravenously with HCF (2 mg/kg per 12 hours). After 4 weeks of ligation, cardiac function and left ventricle reconstructing index were measured. The heart was taken out and the ratio of infarction area to ischemia area was the infarction range. Cell apoptosis was detected by TUNEL straining, and the expression of bcl-2 protein was analyzed by western blot. Results: Compared with the sham-operation group, left ventricular end-diastolic volume (LVESV), relative weight and wall thickness were all significantly increased (t = 3.598, 2.348, 2.324, P < 0.05-0.01), and the left ventricular fraction of shortening (LVFS) and left ventricular ejection fraction (LVEF) were both decreased (t = 4.311, 3.330, P < 0.01). LVESV and LVEDV in the intervention group were significantly lower than those in the control group (t = 2.810, 2.449, P < 0.01); while LVFS and LVEF were increased greatly. Cell apoptotic rate and infarction size in HGF intervention group were significantly lower than that in the control group (t = 2.302, 2.344, P < 0.01). Left ventricular diameter was positively correlated with myocardial apoptotic rate (r = 0.801, P < 0.01). The expression of bcl-2 protein (gray value was 1.37) in the intervention group was significantly higher than that in the control group (gray value was 0.17) (t = 21.043, P < 0.01). Conclusion: HGF can reduce infarction area, decrease the rate of cardiomyocyte apoptosis, restrict the left ventricular remodeling after AMI and improve left ventricular function. The mechanism is probably associated with its anti-apoptosis.